Associated Press
Associated Press 16 Nov 2020

Moderna says its COVID-19 shot is 94.5% effective ++WAIT FOR WIRE++


More promising news on the vaccine front: Moderna says its vaccine provides strong protection against COVID-19. Monday's announcement comes a week after a competitor, Pfizer, revealed its own vaccine to be similarly effective. (Nov. 16)àS±

With infections surging worldwide, and governments struggling to respond, there has been another breakthrough in the hunt for a COVID-19 vaccine.
US pharmaceutical firm Moderna says early tests show its vaccine is 94.5 percent effective in preventing the virus.
Pfizer and BioNTech reported similarly promising results a week ago.

Al Jazeera's Alan Fisher reports from the US capital, Washington, DC.
Drugmaker Moderna says if granted emergency authorization by the FDA, it could roll doses of the vaccine as early as December.
Moderna said today its coronavirus vaccine is 94.5% effective, similar to early results released by Pfizer last week, making it the second vaccine in the US to have a stunningly high success rate. Noubar Afeyan, Moderna co-founder and chairman, says the company's innovations enable it to "keep the vaccine under refrigeration conditions for up to 30 days," enabling broad distribution.
American pharmaceutical company Moderna announced on Monday that its COVID-19 vaccine candidate is nearly 95% effective. The news comes one week after Pfizer announced its inoculations are also successful. CBS News chief medical correspondent Dr. Jon LaPook has the latest.

Share Video:

Embed Video: